Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

DYSPORT

abobotulinumtoxinA

Standard Dose
300 UNITS/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DYSPORT is listed in Drugs@FDA under application 125274 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient abobotulinumtoxinA Form and strength INJECTABLE; INJECTION - 300 UNITS/VIAL Sponsor IPSEN BIOPHARM LTD Submission history Latest submission status date: 2023-09-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview DYSPORT is listed in Drugs@FDA under application 125274 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient abobotulinumtoxinA Form and strength INJECTABLE; INJECTION - 300 UNITS/VIAL Sponsor IPSEN BIOPHARM LTD Submission history Latest submission status date: 2023-09-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.